Table 2.
Variable | Control (n=100) | Observation (n=100) | ||
---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | |
MiR-21 | 4.33±2.01 | 2.81±1.18* | 4.08±1.84 | 1.66±0.79*,** |
TNF-α (pg/mL) | 26.87±7.92 | 22.12±5.48* | 25.56±7.01 | 16.98±4.32*,** |
NSE (ng/mL) | 25.13±5.34 | 16.87±3.21* | 26.88±5.68 | 8.85±2.96*,** |
SCC-Ag (ng/mL) | 24.06±6.98 | 17.97±3.77* | 24.23±4.01 | 10.99±2.46*,** |
CEA (ng/mL) | 99.45±20.86 | 82.64±13.97* | 97.53±18.66 | 54.69±8.53*,** |
P<0.05: before treatment vs. after treatment;
P<0.05: observation group vs. control group.